NASDAQ:ACCD

Accolade Wins 2024 Artificial Intelligence Excellence Award

Retrieved on: 
Wednesday, March 20, 2024
Natural language processing, Automation, Health, Natural language, Philosophy, Observation, AI, Artificial intelligence, Medical device

SEATTLE, March 20, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) today announced it has been named a winner of the Business Intelligence Group's Artificial Intelligence Excellence Awards program for its application of Natural Language Processing. This award recognizes companies leveraging AI technology to solve real-world problems. Accolade is one of the only healthcare organizations recognized this year for excellence in AI.

Key Points: 
  • SEATTLE, March 20, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) today announced it has been named a winner of the Business Intelligence Group's Artificial Intelligence Excellence Awards program for its application of Natural Language Processing.
  • Accolade is one of the only healthcare organizations recognized this year for excellence in AI.
  • Accolade partners with Observe.AI , a live conversation intelligence platform for contact centers, to improve how it scores call center interactions for empathetic conversations.
  • "We are truly honored to recognize Accolade with this prestigious award," stated Maria Jimenez, Chief Nominations Officer for the Business Intelligence Group.

Accolade Promotes Kelsi McDonald Harris to Chief People Officer

Retrieved on: 
Tuesday, March 19, 2024
Arizona State University, Business, Business administration, Target Corporation, Acquisition, IPO, NPS, Senior, ACCD, Workplace, Human resources, Courage, Management

SEATTLE, March 19, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today the promotion of Kelsi McDonald Harris as Chief People Officer and Senior Vice President.

Key Points: 
  • SEATTLE, March 19, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today the promotion of Kelsi McDonald Harris as Chief People Officer and Senior Vice President.
  • In her seven years at Accolade, Kelsi has demonstrated the courage, vision, and tenacity required to be that leader.
  • As Chief People Officer, McDonald Harris will oversee employee experience for Accolade's 2,400+ employees and foster community, connection, and cultural alignment within the organization.
  • Prior to Accolade, McDonald Harris held Human Resources roles at Target Corporation.

Accolade Welcomes Brightline to Trusted Partner Ecosystem

Retrieved on: 
Tuesday, February 27, 2024
Anxiety, Mental health, Caregiver, Adolescence, American Academy, ACCD, Lyra, Parent, Headspace, Health, Accolade, Nursing care plan, Frustration, Depression, Family, Burnout, ADHD, Psychiatry, Trusted Partner, Equip, Bentham Science Publishers, Partnership, Nursing

SEATTLE, Feb. 27, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today that Brightline, a comprehensive pediatric behavioral health solution built for children, teens, their parents, and caregivers, has joined the company's Trusted Partner Ecosystem. The Brightline partnership builds on Accolade's existing behavioral health partnerships with Headspace, Lyra, and Equip and internal capabilities, including an in-house behavioral health advocacy team, Accolade Care therapists, and consulting psychiatrists.

Key Points: 
  • Partnership expands access to high-quality, affordable adolescent and children's behavioral health services
    SEATTLE, Feb. 27, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today that Brightline, a comprehensive pediatric behavioral health solution built for children, teens, their parents, and caregivers, has joined the company's Trusted Partner Ecosystem.
  • The Brightline partnership builds on Accolade's existing behavioral health partnerships with Headspace, Lyra, and Equip and internal capabilities, including an in-house behavioral health advocacy team, Accolade Care therapists, and consulting psychiatrists.
  • We help them move through the daunting barriers to care access," said Nancy Costlow, Accolade Senior Director, Clinical Shared Services.
  • We are thrilled to partner with Accolade to help drive awareness of Brightline's solution and improve access to a critical benefit that is missing for many families today."

Accolade Welcomes Kindbody to Trusted Partner Ecosystem

Retrieved on: 
Tuesday, January 23, 2024
Fertility, Infertility, Health, IVF, Partnership, Female, Male, Menopause, Workplace, Genetic testing, Trusted Partner, Education, ACCD, Birth control

SEATTLE, Jan. 23, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) today announced that Kindbody, a technology-driven fertility clinic network and family-building benefits provider for employers, will join the company's Trusted Partner Ecosystem to offer Accolade customers comprehensive, clinically guided support and care throughout a member's fertility and family-building journey, all backed by a new cost savings performance guarantee.

Key Points: 
  • Kindbody addresses these issues by providing affordable fertility care and delivering a seamless, integrated experience with best-in-class outcomes.
  • Kindbody delivers this model through a combination of owned and operated signature clinics and hundreds of partner clinics nationwide.
  • Joint customers of Accolade and Kindbody will benefit from integrations designed to promote awareness of Kindbody's services, at no incremental cost to customers.
  • Launched in 2019, Accolade's Trusted Partner Ecosystem is the first in the industry to bring together multiple benefits solutions across valued categories, making them available to employers through a single front door.

Accolade Named to 2023 Deloitte Technology Fast 500™

Retrieved on: 
Wednesday, November 8, 2023
Fintech, Deloitte Technology Fast 500, Perseverance, Accolade, LLP, Telecommunications, Software, Creativity, Video game

SEATTLE, Nov. 8, 2023 /PRNewswire/ -- Accolade today announced it has been named to the Deloitte Technology Fast 500™, a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 29th year. Accolade grew 227% during this period.

Key Points: 
  • SEATTLE, Nov. 8, 2023 /PRNewswire/ -- Accolade today announced it has been named to the Deloitte Technology Fast 500 ™, a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 29th year.
  • Accolade's chief executive officer, Rajeev Singh, credits a deeply differentiated approach and the dedication of the entire Accolade team with the company's revenue growth.
  • He said, "Accolade is honored to be included in this year's Technology Fast 500 list which recognizes our extraordinary growth over the last three years.
  • "Each year we look forward to reviewing the progress and innovations of our Technology Fast 500 winners.

GLP-1 Coverage in Employer Plans Could Nearly Double in 2024

Retrieved on: 
Monday, October 9, 2023
Health, Perception, Obesity, Research, Weight loss, HR, MD, ACCD, Risk, Publication, Blood pressure, Pulse, Average high cost multiple, Physician, Nursing, Health insurance, Savanta ComRes

SEATTLE, Oct. 9, 2023 /PRNewswire/ -- Accolade (Nasdaq: ACCD) announced today findings from an employer survey on sentiment and adoption of GLP-1 medications. A key finding: while 81% of human resource (HR) decision-makers feel that their employees would be interested, only 25% cover GLP-1s today.

Key Points: 
  • A key finding: while 81% of human resource (HR) decision-makers feel that their employees would be interested, only 25% cover GLP-1s today.
  • "These findings mirror the conversations we're having with customers," said James Wantuck, MD, Accolade associate chief medical officer.
  • "This survey provides a helpful pulse on the HR community's need for a game plan around GLP-1 medications.
  • The main obstacles to incorporating GLP-1 medications are lack of trusted information and the perceived high cost associated with them.

Accolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare Experience

Retrieved on: 
Monday, September 18, 2023
Doctor of Medicine, Medicine, NCQA, Accreditation, MSN, Rollins, Health equity, Pharmacy, COVID, Social, Pharmacist, National Committee, Vanderbilt, Investment, Physician, Stanford University Medical Center, Patient, Nursing, Quality assurance, Case management, RN, Confusion, Empathy, Health, MPH, National Committee for Quality Assurance, Management, MD, Accolade

SEATTLE, Sept. 18, 2023 /PRNewswire/ -- Accolade (Nasdaq: ACCD) announced the expansion of its care delivery team, strengthening the company's ability to streamline healthcare experiences through physician-led advocacy. Connie Hwang, MD, MPH, joins Accolade to lead population health strategies for employers and health plans. Led by Shantanu Nundy, MD, executive vice president, chief health officer, the care delivery leadership team includes Dr. Hwang, senior vice president, chief medical officer; James Wantuck, MD, senior vice president, associate chief medical officer and co-founder of PlushCare; Kate Rollins, MSN, RN, senior vice president assuming the newly created role of chief nursing officer.

Key Points: 
  • Through our investments in care delivery and physician executive leaders, Accolade is making access to high-quality care a reality for employers, who provide over half of Americans with healthcare insurance," said Rajeev Singh, Accolade CEO.
  • "We welcome Dr. Hwang, who brings substantial experience in population health and integrated care to our accomplished team of physician leaders."
  • We close the critical gaps in the care experience that impact members' health outcomes, costs of care, and overall healthcare experience.
  • She brings extensive experience in working with employer and health plan executives to accelerate clinical innovation, value-based care and care delivery transformation.

Equip Partnership Adds Eating Disorder Support to Accolade's Trusted Partner Ecosystem

Retrieved on: 
Wednesday, June 7, 2023
Insurance, Trusted Partner, Equip, Eating disorder, Opioid, ACCD, COVID-19, Brain, Accolade, Patient, Child, Eating, Mortality, Environment, Nursing, Online shopping

SEATTLE, June 7, 2023 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), the company that provides millions of people and their families with Personalized Healthcare, has partnered with Equip, a virtual evidence-based treatment program that helps patients recover from eating disorders at home. This addition to Accolade's Trusted Partner Ecosystem brings critical new services to individuals struggling with an eating disorder, providing a safe and effective environment for recovery aligned to the gold standard for treating eating disorders.

Key Points: 
  • This addition to Accolade's Trusted Partner Ecosystem brings critical new services to individuals struggling with an eating disorder, providing a safe and effective environment for recovery aligned to the gold standard for treating eating disorders.
  • Equip joins Accolade's Trusted Partner Ecosystem; brings new services to those struggling with eating disorders.
  • In the wake of the COVID-19 pandemic, eating disorder rates have risen dramatically , with hospital admissions doubling.
  • Growing our Trusted Partner Ecosystem with partners like Equip not only increases members' access to these healthcare innovations, but it truly can change lives."

Report: Employees are Overwhelmed, Delaying Care at High Rates

Retrieved on: 
Monday, June 5, 2023
High, Face, Health, Marketing, Health equity, Kaiser Family Foundation, Appetite, CNBC, Confusion, Diagnosis, BIPOC, Health insurance, Nursing, Savanta ComRes, Accolade

SEATTLE, June 5, 2023 /PRNewswire/ -- Accolade (Nasdaq: ACCD), the company that provides millions of people and their families with Personalized Healthcare, announced today findings of a new Savanta employer healthcare survey that shows nearly half of employees (49%) are overwhelmed by managing their own and their family members' healthcare and about two-thirds (65%) have delayed or avoided care as a result.

Key Points: 
  • Employees are Overwhelmed, Delaying Care at High Rates  - new report explores causes of stress, solutions for employers.
  • The report also explores barriers to care, including health equity, and an increasing appetite for free and low-cost virtual care among consumers.
  • "Even with health insurance to help cover the high cost of healthcare, people are feeling stuck when it comes to seeking the care they need.
  • Personalize experiences to address barriers to care: As employees face different barriers to care, a single approach may not fit your entire population.

Accolade Welcomes Lyra Health to Its Trusted Partner Ecosystem

Retrieved on: 
Monday, March 6, 2023
Gallup, Depression, Workplace, Mental, Lyra, Trusted Partner, Partnership, Mental health, Anxiety, ACCD, Psychiatry, Nursing, Accolade

SEATTLE, March 6, 2023 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), the company that provides millions of people and their families with Personalized Healthcare, has partnered with Lyra Health, a leading provider of global workforce mental health solutions. By adding Lyra to its Trusted Partner Ecosystem, Accolade is building on its commitment to offer best-in-class behavioral health solutions to its customers through both strategic partnerships and in-house capabilities. 

Key Points: 
  • SEATTLE, March 6, 2023 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), the company that provides millions of people and their families with Personalized Healthcare, has partnered with Lyra Health, a leading provider of global workforce mental health solutions.
  • By adding Lyra to its Trusted Partner Ecosystem , Accolade is building on its commitment to offer best-in-class behavioral health solutions to its customers through both strategic partnerships and in-house capabilities.
  • "Mental health is the defining problem of our time, and the biggest hurdle is finding fast access to high quality care," said Dr. Connie Chen, chief operating officer of Lyra Health.
  • Joint customers of Accolade and Lyra Health will benefit from purpose-built integrations between these services at no incremental cost.